Phase 1
Completed N=6
Augmenting Flortaucipir Dosimetry Estimates
Source: ClinicalTrials.gov NCT02336360 ↗Enrolled (actual)
6
Serious AEs
—
Results posted
Aug 2020
Primary outcomePrimary: Urine Analysis - Total Integrated Radioactivity Excreted in Urine — 0.1413 megabecquerel-hours per megabecquerel
Summary
This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Urine Analysis - Total Integrated Radioactivity Excreted in Urine |
0.1413 | — |
Eligibility Criteria
Inclusion Criteria
- Subjects who passed screening in an Avid-sponsored study in which flortaucipir will be administered
Exclusion Criteria
- Subjects who have withdrawn informed consent
- Investigator or sponsor believes it is in the best interest of the subject to be removed from the trials
Data sourced from ClinicalTrials.gov (NCT02336360). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.